Your browser doesn't support javascript.
loading
Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs.
Torrey, Heather; Butterworth, John; Mera, Toshiyuki; Okubo, Yoshiaki; Wang, Limei; Baum, Danielle; Defusco, Audrey; Plager, Sara; Warden, Sarah; Huang, Daniel; Vanamee, Eva; Foster, Rosemary; Faustman, Denise L.
Afiliação
  • Torrey H; Immunobiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
  • Butterworth J; Immunobiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
  • Mera T; Immunobiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
  • Okubo Y; Immunobiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
  • Wang L; Immunobiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
  • Baum D; Immunobiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
  • Defusco A; Immunobiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
  • Plager S; Immunobiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
  • Warden S; Immunobiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
  • Huang D; Immunobiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
  • Vanamee E; Immunobiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
  • Foster R; Department of Obstetrics and Gynecology, Massachusetts General Hospital and Harvard Medical School, Vincent Center for Reproductive Biology, Boston, MA 02114, USA.
  • Faustman DL; Immunobiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA. faustman@helix.mgh.harvard.edu.
Sci Signal ; 10(462)2017 01 17.
Article em En | MEDLINE | ID: mdl-28096513

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Reguladores / Receptores Tipo II do Fator de Necrose Tumoral / Proliferação de Células / Anticorpos Monoclonais Tipo de estudo: Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Sci Signal Assunto da revista: CIENCIA / FISIOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Reguladores / Receptores Tipo II do Fator de Necrose Tumoral / Proliferação de Células / Anticorpos Monoclonais Tipo de estudo: Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Sci Signal Assunto da revista: CIENCIA / FISIOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos